Concepedia

Assia Belhassan

AB

Statistics

Publications

16

Citations

968

H-Index

15

Active since

2017

Affiliations

Université Moulay Ismail de Meknes(Current)

Université Sultan Moulay Slimane

University of Hassan II Casablanca

Sidi Mohamed Ben Abdellah University

King Saud University

Assia Belhassan is an author at Université Moulay Ismail de Meknes specializing in drug discovery, medicinal chemistry, and pharmacy.

ORCID

Publications per year

2017–2022

16

Publications

16

Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations

Ilham Aanouz, Assia Belhassan, Tahar Lakhlifi et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 347 citations · Full text

, , +17

In silico detection of potential inhibitors from vitamins and their derivatives compounds against SARS-CoV-2 main protease by using molecular docking, molecular dynamic simulation and ADMET profiling

Assia Belhassan, Samir Chtita, Hanane Zaki et al. · Journal of Molecular Structure · 2022 · 70 citations · Full text

, , +17

QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia

Mohamed El fadili, Mohammed Er-rajy, Mohammed Kara et al. · Pharmaceuticals · 2022 · 70 citations · Full text

, , +17

QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods

Samir Chtita, Assia Belhassan, Mohamed Bakhouch et al. · Chemometrics and Intelligent Laboratory Systems · 2021 · 68 citations · Full text

, , +17

Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening

Samir Chtita, Assia Belhassan, Adnane Aouidate et al. · Combinatorial Chemistry & High Throughput Screening · 2020 · 60 citations

, , +17

1–5 of 16